Addison Advisors’s Amdocs DOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.87K Sell
136
-43
-24% -$2.64K ﹤0.01% 455
2026
Q1
$11.7K Sell
179
-50
-22% -$3.66K ﹤0.01% 641
2025
Q4
$18.4K Sell
229
-28
-11% -$2.25K ﹤0.01% 555
2025
Q3
$21.1K Buy
257
+6
+2% +$520 ﹤0.01% 545
2025
Q2
$22.9K Sell
251
-16
-6% -$1.43K 0.01% 521
2025
Q1
$24.4K Hold
267
0.01% 479
2024
Q4
$22.7K Hold
267
0.01% 488
2024
Q3
$23.4K Hold
267
0.01% 490
2024
Q2
$21.1K Buy
+267
New +$21.9K 0.01% 482

Other funds holding DOX

Addison Advisors's DOX Position: Q2 2026 in Review

Addison Advisors reduced its Amdocs (DOX) stake by 24% in Q2 2026, selling an estimated $2.64K and leaving 136 shares worth $6.87K. The position accounts for ﹤0.01% of the portfolio, ranked #455.

Addison Advisors first reported a position in DOX in Q2 2024 and has held it in 9 quarters since. The position peaked at $24.4K in Q1 2025. 448 funds tracked by Wall St. Rank hold DOX as of Q2 2026.

  • Addison Advisors held 136 shares of Amdocs worth $6.87K as of Q2 2026.
  • Addison Advisors sold 43 Amdocs shares in Q2 2026, an estimated $2.64K.
  • Amdocs made up ﹤0.01% of Addison Advisors's portfolio in Q2 2026, its #455 holding.
  • Addison Advisors first reported a position in Amdocs in Q2 2024 and has held it in 9 quarters since.
  • Addison Advisors's Amdocs position peaked at $24.4K in Q1 2025.
  • 448 funds tracked by Wall St. Rank held Amdocs as of Q2 2026.

Based on Addison Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.